A detailed history of London & Capital Asset Management LTD transactions in Amgen Inc stock. As of the latest transaction made, London & Capital Asset Management LTD holds 122,135 shares of AMGN stock, worth $36 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares
122,135
Previous 122,734 0.49%
Holding current value
$36 Million
Previous $38.3 Million 2.62%
% of portfolio
3.15%
Previous 3.26%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $185,318 - $202,090
-599 Reduced 0.49%
122,135 $39.4 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $7.12 Million - $8.66 Million
-27,117 Reduced 18.1%
122,734 $38.3 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $196,812 - $237,577
-732 Reduced 0.49%
149,851 $42.6 Million
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $2.19 Million - $2.47 Million
-8,551 Reduced 5.37%
150,583 $43.4 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $5.32 Million - $6.61 Million
24,344 Added 18.06%
159,134 $42.8 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2.39 Million - $2.82 Million
-11,143 Reduced 7.64%
134,790 $29.9 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $1.24 Million - $1.52 Million
-5,506 Reduced 3.64%
145,933 $35.3 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $3.5 Million - $4.45 Million
-15,275 Reduced 9.16%
151,439 $39.8 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $15,936 - $17,973
-71 Reduced 0.04%
166,714 $37.6 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $712,893 - $793,326
3,090 Added 1.89%
166,785 $40.6 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $1.92 Million - $2.12 Million
-8,759 Reduced 5.08%
163,695 $39.6 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $5.59 Million - $6.4 Million
28,124 Added 19.49%
172,454 $38.8 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $30.6 Million - $35.9 Million
144,330 New
144,330 $30.7 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $26.2 Million - $29 Million
-111,994 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $697,685 - $813,038
3,144 Added 2.89%
111,994 $27.9 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $1.92 Million - $2.29 Million
8,875 Added 8.88%
108,850 $25 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $329,448 - $366,373
-1,404 Reduced 1.38%
99,975 $25.4 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $2.28 Million - $2.79 Million
-11,505 Reduced 10.19%
101,379 $23.9 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $2.94 Million - $3.89 Million
16,108 Added 16.64%
112,884 $22.9 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $17.3 Million - $22.3 Million
91,497 Added 1733.23%
96,776 $23.3 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $6,442 - $7,718
-37 Reduced 0.7%
5,279 $1.02 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $79,182 - $92,819
-475 Reduced 8.2%
5,316 $980,000
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $166,400 - $187,569
-920 Reduced 13.71%
5,791 $1.1 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $1.2 Million - $1.4 Million
6,711 New
6,711 $1.31 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track London & Capital Asset Management LTD Portfolio

Follow London & Capital Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on London & Capital Asset Management LTD with notifications on news.